Guangzhou Baiyun Mountain Hutchison Whampoa Chinese Medicine Co., Ltd.

Guangzhou Baiyun Mountain Hutchison Whampoa Chinese Medicine Co., Ltd. was established by Hutchison Whampoa (China) Co., Ltd., the richest man in China, and Guangzhou Baiyun Mountain Pharmaceutical Co., Ltd. in May 2005. The company is committed to the research, development and manufacture of modern Chinese medicine, and promotes the culture of Chinese medicine with the development direction of "modernization, internationalization, popularization and popularization of Chinese medicine".

The company adheres to the enterprise purpose of "improving product quality, accelerating technological progress, improving management level and promoting the modernization of traditional Chinese medicine". On the one hand, relying on Baiyun Mountain's strong brand advantage and first-class scientific research strength, on the other hand, relying on Hutchison Whampoa's huge international influence and strong financial strength, the two sides can share resources and complement each other.

In the strategy of promoting the modernization of traditional Chinese medicine, Baiyunshan and Huangzhong actively carried out scientific research and established a research and development platform without walls. We have successively established cooperative relations with enterprises and universities in China, Hongkong, France and Japan, and undertaken national, provincial and municipal scientific and technological projects 13. Traditional Chinese medicine extraction, tablet coating, fingerprint of traditional Chinese medicine and GAP construction are at the leading level in China. Established the largest GAP medicinal material base of Radix Isatidis in China, and passed the national certification for the first time in China. Baiyunshan Banlangen became the first batch of international cooperation projects of traditional Chinese medicine in the Ministry of Science and Technology. Established the first "five-level quality control system" in China, which provides consumers with the best quality products and services more effectively and comprehensively than the three-level quality control system required by the state; It took the lead in setting up 30 million "independent innovation" fund in China, building an incentive mechanism for independent innovation of enterprises, setting up the first modern Chinese medicine research institute in South China, employing Ren Dequan, the father of modernization of Chinese medicine, and Zhong Nanshan, president of Chinese Medical Association, as honorary presidents, and eight Chinese medicine giants, including Deng Tietao and Ling Feng, as honorary directors of various research centers, jointly establishing the first "Joint Laboratory of Antibacterial and Anti-inflammatory Chinese Medicine" with Guangzhou University of Chinese Medicine, and establishing "Guangzhou Sino-British Cambridge Science and Technology Pioneer Park Co., Ltd." in cooperation with Cambridge University in

Guided by Mr. Li Ka-shing's concept of "doing public welfare and giving back to the society", the company adheres to the corporate philosophy of "caring for Baiyun Mountain and caring for citizens", promotes love and actively participates in social public welfare activities. In 2005, Baiyunshan and Huangzhong Medicine initiated the "Family Expired Drugs (Free) Recycling Mechanism" to help consumers solve the problem of expired drugs, and won the highest award of "Asia World-class Innovation Record" in Guangdong Province. On June 20th, 2006, 10, Baiyunshan and Huangpi Pharmaceutical made another innovation and started the "Never Expired" pharmacy project, adding 6,600 "Never Expired" pharmacies within two years.

In June 2006, the company built the first "Shennong Caotang" Chinese medicine museum in China, which integrates medicine cultivation, culture, appreciation, leisure and health preservation. Zhang Dejiang, secretary of Guangdong Provincial Party Committee, praised it as "an important achievement in building a strong province of Chinese medicine and a cultural province with far-reaching social influence", and Mr. Li Ka-shing, the richest Chinese, even called it "sincerity and creativity in promoting Chinese medicine culture".

With a strong domestic sales network, the joint venture company will join hands with Hutchison Whampoa, Baijia and more than 5,000 retail terminals in Europe. While deepening the domestic market, it will vigorously enter overseas markets. In the new period and situation, the company will firmly grasp the strategic opportunity of enterprise development, take the goal of becoming an international pioneer enterprise in modern drug production and sales, embark on a solid step of modernization and internationalization of traditional Chinese medicine, and cast the Great Wall of human life and health.